Ola 15 Tablet contains Olanzapine 15 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar disorder. Olanzapine exerts its therapeutic effects by antagonizing multiple neurotransmitter receptors in the brain, including serotonin (5-HT2A/2C), dopamine (D1-4), histamine (H1), and muscarinic receptors, thereby helping to restore the chemical balance and reduce symptoms such as hallucinations, delusions, mood swings, and agitation. This medication is typically prescribed to manage acute psychotic episodes and to maintain symptom control during remission phases. Ola 15 Tablet should be administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include weight gain, sedation, dry mouth, dizziness, and metabolic changes such as increased blood glucose and lipid levels; therefore, regular monitoring of metabolic parameters is recommended during treatment. Caution is advised in patients with cardiovascular disease, diabetes, or a history of seizures. Olanzapine is contraindicated in individuals with known hypersensitivity to the drug and should be used cautiously in elderly patients with dementia-related psychosis due to increased risk of mortality. Patients should be advised to avoid alcohol and inform their healthcare provider of any other medications to prevent potential drug interactions.